Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. (ADXS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ADXS · as of Mar 31, 2022
Ownership Breakdown
3
Institutional Holders
▼ 2 vs Q4
$16,000
Total Inst. Value
▲ $2,999 vs Q4
42.59M
Shares Outstanding
freeFloat 92.68%
137,090
13F Shares Held
▲ 52,438 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ADXS largest shareholders · institutional ownership
Q1 2022 · SEC 13F
Showing top 8 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 59.0K | 1.34% | 1.34% | $7.00M | May 4, 2022 | ▲ 59.0K |
IHT WEALTH MANAGEMENT, LLC pharmaceutical preparations | 58.0K | 1.32% | 1.32% | $7.00M | May 16, 2022 | ▲ 58.0K |
LPL FINANCIAL LLC pharmaceutical preparations | 20.0K | 45.47% | 45.47% | $2.00M | May 16, 2022 | ▲ 8 |
VICTORY CAPITAL MANAGEMENT INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 4, 2022 | EXIT |
SIMON QUICK ADVISORS, LLC pharmaceutical preparations | 33 | 0.00% | 0.00% | $0 | May 5, 2022 | — held |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 12, 2022 | EXIT |
BNP PARIBAS ARBITRAGE, SNC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 18, 2022 | EXIT |
FOUNDERS FINANCIAL SECURITIES LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2022 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2022 vs prior quarter
Q1 2022
3
Increased
+117.1K shares0
New Positions
first time holders0
Decreased
−0 shares4
Sold Out
fully exitedNet shares change (top 50)
+117.1K
+117.1K / −0
Net new holders
-1
0 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ADXS insider trading · insider activity
Source: SEC Form 4
10
Buy transactions
1
Sell transactions
10.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Israel Biotech Fund I, L.P.
| Feb 7, 2024 | Tax Withhold | 2,586,905 | $1.25 | $3.22M | 25.13M | Form 4 ↗ |
Israel Biotech Fund I, L.P.
| Feb 7, 2024 | Tax Withhold | 2,707,581 | $1.25 | $3.37M | 20.66M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ayala Pharmaceuticals, Inc. (ADXS) is primarily owned by institutional investors, who hold approximately 0.3% of total shares outstanding. Company insiders own approximately 7.32%, while retail and public investors account for the remaining 92.35%.
The largest institutional shareholder of Ayala Pharmaceuticals, Inc. is ADVISOR GROUP HOLDINGS, INC., holding approximately 59,041 shares — equal to 1.34% of outstanding shares — as of March 31, 2022.
A total of 3 institutional investors currently hold ADXS stock, with a combined institutional value of approximately $16,000 as of the most recent 13F filing period.
Frequently asked questions
ADXS ownershipAyala Pharmaceuticals, Inc. (ADXS) is primarily owned by institutional investors, who hold approximately 0.3% of shares. The largest shareholder is ADVISOR GROUP HOLDINGS, INC. with a 1.34% stake. Company insiders hold 7.32%. Data sourced from SEC Form 13F as of March 31, 2022.